Concepedia

Publication | Open Access

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

DOIFull Paper Access

151

Citations

19

References

2014

Year

W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela Perry, Na Jin, Timothy Peters-Strickland, B. Johnson, Ross A. Baker, Anna Eramo, Robert D. McQuade, William H. Carson,
The British Journal of Psychiatry

Abstract

Aripiprazole once-monthly 400 mg was non-inferior to oral aripiprazole, and the reduction in Kaplan-Meier estimated impending relapse rate at week 26 was statistically significant v. aripiprazole once-monthly 50 mg.

References

YearCitations

Page 1